Synopsis
Fixed energy minifocus beamline
Status:
open
Disciplines
Applications
- MASSIF-3 is a minifocus beamline (15 µm diameter), operating at fixed energy (12.81 keV). The beamline is dedicated to protein crystals of small size, inhomogeneous protein crystals, and fast data collection, and is also suitable for SAD measurements (Se, Pt, Au,...). MASSIF-3 is equipped with a MD2 micro-diffractometer and with a FlexHCD sample changer for SPINE pucks and UniPucks. Diffraction data are recorded on a Eiger1 X 4M detector that allows data collection at a very high frame rate (up to 750 Hz). The high resolution limit on the beamline is 1.17 Å.
Techniques
-
Anomalous diffraction
-
MX - macromolecular crystallography
-
Microbeam
-
Microcrystallography
-
Optical spectroscopy
-
Single-crystal diffraction
-
XRD - X-ray diffraction
Beam size
- Minimum (H x V) : 15.0
x 15.0
µm²
-
Maximum (H x V) : 15.0
x 15.0
µm²
Sample environments
- 100 K cryostream
- automatic sample changer
- dehydration device
- online microspec
Detectors
Technical details
High resolution limit - 1.17Å
References:
ID30A-3 (MASSIF-3) – a beamline for macromolecular crystallography at the ESRF with a small intense beam, D. Von Stetten et al., J. Synchrotron Radiat. (2020) 27: 844–851. doi: 10.1107/S1600577520004002
The Upgrade Programme for the Structural Biology beamlines at the European Synchrotron Radiation Facility – High throughput sample evaluation and automation, P. Theveneau et al. (2013) J. Phys.: Conf. Ser. 425 012001 doi:10.1088/1742-6596/425/1/012001
Add this RSS feed to your favorite RSS reader (Thunderbird, Outlook etc...) or install an add-on to your browser, such as RSSPreview for Firefox
Mechanistic insights into substrate recognition of human nucleoside diphosphate kinase C based on nucleotide-induced structural changes
Amjadi R., Werten S., Lomada S., Baldin C., Scheffzek K., Dunzendorfer-Matt T., Wieland T.,
International Journal of Molecular Sciences 25, 9768-1-9768-19 (2024)
A potent agonist-based PROTAC targeting Pregnane X Receptor that delays colon cancer relapse
Bansard L., Laconde G., Delfosse V., Huet T., Ayeul M., Rigal E., Donati Q., Gerbal-Chaloin S., Daujat-Chavanieu M., Legrand B., Chavanieu A., Martin A.R., Pannequin J., Bourguet W., Amblard M., Pascussi J.M.,
BioRxiv , 062224 (2024)
PrgE: An OB-fold protein from plasmid pCF10 with striking differences to prototypical bacterial SSBs
Breidenstein A., Lamy A., Bader C.P.J., Sun W.S., Wanrooij P.H., Berntsson R.P.A.,
Life Science Alliance 7, e202402693-1-e202402693-14 (2024)
4'-ethynyl-2'-deoxycytidine (EdC) preferentially targets lymphoma and leukemia subtypes by inducing replicative stress
Calbert M.L., Chandramouly G., Adams C.M., Saez-Ayala M., Kent T., Tyagi M., Ayyadevara V.S.S.A., Wang Y., Krais J.J., Gordon J., Atkins J., Toma M.M., Betzi S., Boghossian A.S., Rees M.G., Ronan M.M., Roth J.A., Goldman A.R., Gorman N., Mitra R., Childers W.E., Graña X., Skorski T., Johnson N., Hurtz C., Morelli X., Eischen C.M., Pomerantz R.T.,
Molecular Cancer Therapeutics 23, 683-699 (2024)
Bdellovibrio bacteriovorus uses chimeric fibre proteins to recognize and invade a broad range of bacterial hosts
Caulton S.G., Lambert C., Tyson J., Radford P., Al-Bayati A., Greenwood S., Banks E.J., Clark C., Till R., Pires E., Sockett R.E., Lovering A.L.,
Nature Microbiology 9, 214-227 (2024)
Discovery and optimization of 4-pyrazolyl-2-aminopyrimidine derivatives as potent spleen tyrosine kinase (SYK) inhibitors
Cervi G., D'Alessio R., Bindi S., Buffa L., Burocchi A., Canevari G., Modugno M., Motto I., Saturno G., Orsini P.,
European Journal of Medicinal Chemistry 270, 116375-1-116375-17 (2024)